|Year : 2017 | Volume
| Issue : 4 | Page : 577-580
Prevalence of thyroid peroxidase antibody and pregnancy outcome in euthyroid autoimmune positive pregnant women from a tertiary care center in Haryana
Rajesh Rajput1, Tekchand Yadav1, Shashi Seth2, Smiti Nanda3
1 Department of Endocrinology and Medicine Unit V, Pt. B. D. Sharma Postgraduate Institute of Medical Sciences, Rohtak, Haryana, India
2 Department of Biochemistry, Pt. B. D. Sharma Postgraduate Institute of Medical Sciences, Rohtak, Haryana, India
3 Department of Obstertrics and Gynaecology, Pt. B. D. Sharma Postgraduate Institute of Medical Sciences, Rohtak, Haryana, India
|Date of Web Publication||9-Jun-2017|
Department of Endocrinology and Medicine Unit VI, Pt. B. D. Postgraduate Institute of Medical Sciences, Rohtak - 124 001, Haryana
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Objective: To study the prevalence of thyroid peroxidase autoantibody in euthyroid pregnant women and to evaluate the association between thyroid peroxidase autoantibody and pregnancy outcomes. Materials and Methods: One thousand thirty consecutive pregnant women attending the antenatal clinic over a period of 1 year and were carrying a healthy singleton uncomplicated intrauterine pregnancy and consuming iodized salt were recruited for the study. Outcomes of the pregnancy was compared between TPO antibody positive euthyroid women (group 1) and TPO antibody negative euthyroid women (group 2). Results: Out of 1030 women, 164 (18.9%) were detected TPO antibody positive with euthyroid status. The mean FT4 and TSH level were significantly different in those who were TPO Ab positive as compared TPO Ab negative euthyroid pregnant women. No correlation was observed between the maternal age, gestational age and gravidity with anti TPO antibody levels. Eighteen (12%) women in Group 1and 5 (3.3%) women in Group 2 had miscarriages and the difference was found to be statistically significant (P value of 0.004). Twenty-one (14%) women in Group 1 and 5 (3.3%) women in Group 2 had preterm deliveries, which was also found to be statistically significantly (p value of 0.001). Other pregnancy related complications like Intrauterine death, IUGR, preeclampsia and PIH though are present in comparatively higher number in TPO Ab positive euthyroid pregnant women as compared to TPO Ab negative euthyroid pregnant women but this difference was not found to be statistically significant. Conclusions: To conclude with the present study shows that a good number of pregnant women with euthyroid status have TPO Ab positivity and this is associated with some adverse pregnancy outcomes like miscarriage and preterm birth of the baby.
Keywords: Euthyroid, pregnancy outcome, TPO autoantibody
|How to cite this article:|
Rajput R, Yadav T, Seth S, Nanda S. Prevalence of thyroid peroxidase antibody and pregnancy outcome in euthyroid autoimmune positive pregnant women from a tertiary care center in Haryana. Indian J Endocr Metab 2017;21:577-80
|How to cite this URL:|
Rajput R, Yadav T, Seth S, Nanda S. Prevalence of thyroid peroxidase antibody and pregnancy outcome in euthyroid autoimmune positive pregnant women from a tertiary care center in Haryana. Indian J Endocr Metab [serial online] 2017 [cited 2021 Jul 23];21:577-80. Available from: https://www.ijem.in/text.asp?2017/21/4/577/207690
| Introduction|| |
Evaluation of thyroid disease in pregnancy is important for maternal health, obstetrical outcome, and subsequent development of the child., Thyroid diseases are different from other diseases in terms of their ease of diagnosis, accessibility of medical treatment, and the relative visibility that even a small swelling of thyroid offers to the treating physician. It has been recognized that pregnant women who are euthyroid but who are positive for thyroid peroxidase autoantibody (TPO Ab) are at increased risk of various complications of pregnancy including miscarriage, preterm birth, pregnancy-induced hypertension (PIH), intrauterine death (IUD), and intrauterine growth retardation (IUGR)., Various reasons cited to explain this association include the fact that the presence of thyroid antibodies may represent a marker of a generalized autoimmune imbalance that is responsible for an increased miscarriage rate, increased chances of these women to develop subclinical, or overt hypothyroidism during pregnancy  and finally, these women are often older than those without, so an older age, per se, may explain the increased rate of fetal loss., Many western studies had confirmed this association; however, little information is available from India and none from Haryana which is supposed to be iodine sufficient.,,
| Materials and Methods|| |
This was a cross-sectional study conducted at the Department of Endocrinology and Antenatal Clinic in Department of Obstetrics and Gynecology at Postgraduate Institute of Medical Sciences, Rohtak. A total number of 1030 pregnant women who attend antenatal clinic over a period of 1 year were recruited for the study. After explaining the purpose of the study, informed consent was obtained and Institutional Ethical Review Board approved the study. All women who were carrying a healthy singleton uncomplicated intrauterine pregnancy and consuming iodized salt were recruited. On enrollment of participants, detailed history was enquired. All participants were subjected to relevant general physical examination including the presence or absence of goiter and findings were recorded on a predesigned pro forma. Participants having any history of chronic illness, goiter on physical examination, thyroid illness in the past or present, consuming thyroid medications (current and past), family history of thyroid illness, and poor obstetrics history (3 or more abortions) were excluded from the study. Estimation for free triiodothyronine (FT3), free thyroxine (FT4), and thyroid-stimulating hormone (TSH) was done using the electrochemiluminescence technique using commercially available kits by Advia Centaur CP analyzer system. Immulite 1000 anti-TPO Ab solid phase, enzyme-labeled chemiluminescent sequential immunometric assay was used for the measurement of TPO antibodies. The analytical sensitivities for FT3, FT4, TSH, and anti-TPO were 0.2 pg/mL, 0.1 ng/dL, 0.010 μIU/mL, and 7 IU/mL, respectively. Intraassay coefficients of variation for FT3, FT4, TSH, and anti-TPO were 3.8%, 2.20%, 5.2%, and 5.6%, respectively. Laboratory reference ranges for FT3, FT4, and TSH were 2.3–4.2 pg/mL, 0.89–1.76 ng/dL, and 0.35–5.5 mIU/L, respectively. Normal range for TPO Ab was <35 IU/mL and value greater than or equal to indicate elevated anti-TPO in serum. American Association of Clinical Endocrinologist guidelines were used for the classification of pregnant women thyroid status. Those having TSH level ≤2.5 μIU/mL in first trimester and TSH level ≤3.0 μIU/m in second and third trimester with normal FT4 were considered as euthyroid. Euthyroid pregnant women with TPO Ab positivity were included in Group 1 and were followed until the completion/termination of their pregnancy. The pregnancy outcomes of pregnant women with euthyroid status and positive TPO Ab (Group 1) were compared with euthyroid pregnant women with TPO Ab negative status (Group 2).
According to the aims and objectives of the study, the data were analyzed using appropriate statistical tests in Statistical Package for Social Sciences (SPSS) version 20 (SPSS Inc. Chicago IL). For descriptive statistics, frequencies, percentages, mean with standard deviations, and median of different variables were calculated. To assess difference between categorical variables, “Chi-square test” was used. Independent sample t-test was used to compare the means of two separate sets of independent samples. For comparison of means of more than two samples, analysis of variance test was used. The P values were two-tailed and probability level of significant difference was set at <0.05.
| Results|| |
The present study was conducted on 1030 consecutive pregnant women attending the antenatal clinic over a period of 1 year. Median time of recruitment of study participant was 9 weeks and 3 days with a range of 6–12 weeks. Out of these 1030 women, 164 (18.9%) were detected TPO Ab positive with euthyroid status and they were recruited in our study. Six women were lost to follow-up; eight women did not give their consent to participate in study; hence, various pregnancy outcomes were noted in remaining 150 TPO Ab positive euthyroid pregnant women. TPO Ab positive euthyroid pregnant women (Group 1) were compared with equal number of TPO Ab negative euthyroid pregnant women (Group 2). Mean bodyweight of women in both the groups was comparable (Group 1 was 54.08 ± 8.05 and Group 2 was 52.45 ± 9.0; P = 0.15). The baseline thyroid profile of both the groups is shown in [Table 1]. The mean FT4 and TSH level were significantly different in those who were TPO Ab positive as compared TPO Ab negative euthyroid pregnant women. No correlation was observed between the maternal age, gestational age, and gravidity with anti-TPO Ab levels.
|Table 1: Baseline thyroid function of euthyroid pregnant women with positive and negative thyroid peroxidase antibody|
Click here to view
Eighteen (12%) women in Group 1 and 5 (3.3%) women in Group 2 had miscarriages, and the difference was found to be statistically significant (P = 0.004). Twenty-one (14%) women in Group 1 and 5 (3.3%) women in Group 2 had preterm deliveries and this difference was statistically significantly (P = 0.001). Other pregnancy-related complications such as IUD, IUGR, preeclampsia, and PIH though are present in comparatively higher number in TPO Ab positive euthyroid pregnant women as compared to TPO Ab negative euthyroid pregnant women, this difference was not found to be statistically significant. The pregnancy-related outcomes between two groups are summarized in [Table 2]. During the study period, seven women in Group 1 and six women in Group 2 developed GDM (P > 0.05).
|Table 2: Association of anti-thyroid peroxidase antibody with pregnancy outcome in euthyroid women in study population|
Click here to view
| Discussion|| |
In the present study, we assessed the prevalence of TPO Ab in euthyroid pregnant women and its relationship with various pregnancy outcomes such as miscarriage, preterm, preeclampsia PIH, IUD, and IUGR. 18.9% pregnant euthyroid women were found to be positive for TPO Ab and significant correlation was observed between TPO Ab positivity and rate of miscarriage and preterm deliveries. Negro et al. and Hollowell et al. observed the presence of TPO Ab in 11.7% and 14.6% of pregnant euthyroid women in their studies, respectively. A study by Bhattacharya et al. observed TPO Ab prevalence of 11.34%. The age of these women in the present study ranged from 17 to 36 years with majority in the age range of 21–25 years and it was not statistical different between TPO Ab positive and TPO Ab negative euthyroid women. The median maternal age in both the Group 1 and 2 was less as compared to Western studies, reflecting early marriage and early conception prevalent in India. No correlation was observed between age and TPO Ab positivity in the present study. Similar observations had been reported from some other studies., However, Negro et al. observed that TPO Ab positive women were more older than anti-TPO Ab negative women. Stricker et al. also found a significant association between anti-TPO and maternal age. Kutteh et al. also observed significant relationship between increasing age and recurrent pregnancy loss associated with elevated antibody status. Abbassi-Ghanavati et al. reported that women who were TPO Ab positive were older, heavier, and more often multiparous than women with negative antithyroid peroxidase antibodies. No correlation between TPO Ab positivity and parity, period of gestation, or body weight was found in the present study.
Among thyroid function tests, FT4 was significantly lower and TSH levels were significantly higher among the TPO Ab positive euthyroid women as compared to TPO Ab negative women in the present study. This rise of thyroid-stimulating hormone concentrations in euthyroid TPO Ab positive women could be due to autoimmune-mediated inflammation of thyroid gland that leads to reduction in the functional reserve of the thyroid gland and is associated with reduced adaptation of thyroid gland to the physiological changes of pregnancy. Similar results were observed by Negro et al. and Prummel and Wiersinga, but Stagnaro-Green et al. did not detect any significant difference between TSH levels and FT4 levels in between TPO Ab positive and TPO Ab negative euthyroid women.
Eighteen (12%) women TPO Ab positivity and 5 (3.3%) women with TPO Ab negative status had miscarriages and the difference was statistically significant (P < 0.004). This could be due to subtle deficiency of thyroid hormone concentrations or a lower capacity of the thyroid gland to adapt to the demands of pregnancy in euthyroid pregnant women with TPO Ab positivity. These results were consistent with the findings of the studies by Stagnaro-Green et al. and Negro et al. It was also seen in our study that maximum number of miscarriages occurred in first trimester (12/18, 67%) as compared to second trimester (06/18, 33%) in Group 1 and this difference was statistically significant. In Group 2, no significant difference was observed in the number of miscarriage in first and second trimester. Similar results were also seen by Negro et al. and Glinoer  and Meena et al. in their studies. Preterm deliveries were observed in 21 (14%) women of TPO Ab positive group and 5 (3.3%) women in TPO Ab negative group and this difference was statistically significant (P = 0.001). These findings were in agreement with those by Negro et al. (22.4% in Group 1 vs. 8.2% in Group 2) and Glinoer  (16.1% in Group 1 vs. 7.9% in Group 2), respectively. However, the study by Männistö et al. and Ligima et al. did not show similar correlation between TPO Ab positive and TPO Ab negative women. The likely reason for higher incidence of preterm deliveries is that the presence of thyroid autoantibodies reflects a generalized activation of the immune system that would have resulted in deregulation of the immune system against the fetal-maternal interface. Although other pregnancy-related complications such as IUD, IUGR, preeclampsia, and PIH were present in higher number of women with TPO Ab positivity, this difference was statistically insignificant (P > 0.05). Similar findings were also observed in the study by Negro et al. and Männistö et al.
| Conclusion|| |
The present study shows that a good number of pregnant women with euthyroid status has TPO Ab positivity and this was found to be associated with adverse pregnancy outcomes such as miscarriage and preterm birth of the baby. One of the limitations of the present study is that we have not studied the role of levothyroxine treatment in prevention of these obstetrics complications. Therefore, larger studies with bigger sample size and population subsets from different geographical regions of country are needed to establish the relationship between TPO Ab and adverse pregnancy outcomes and whether routine estimation of TPO Ab in pregnancy and its treatment is going to benefit the pregnancy outcomes or not needs to be studied.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Sahu MT, Das V, Mittal S, Agarwal A, Sahu M. Overt and subclinical thyroid dysfunction among Indian pregnant women and its effect on maternal and fetal outcome. Arch Gynecol Obstet 2010;281:215-20.
Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. J Clin Endocrinol Metab 2010;95:E44-8.
Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Spong CY, editors. Abortion. Williams Obstetrics. 23rd
ed., Ch. 9. New York: McGraw-Hill; 2010. p. 215-37.
Creasy RK. Preventing preterm birth. N Engl J Med 1991;325:727-9.
van den Boogaard E, Vissenberg R, Land JA, van Wely M, van der Post JA, Goddijn M, et al.
Significance of (sub) clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: A systematic review. Hum Reprod Update 2011;17:605-19.
Stagnaro-Green A, Roman SH, Cobin RH, el-Harazy E, Alvarez-Marfany M, Davies TF. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 1990;264:1422-5.
Lejeune B, Grun JP, de Nayer P, Servais G, Glinoer D. Antithyroid antibodies underlying thyroid abnormalities and miscarriage or pregnancy induced hypertension. Br J Obstet Gynaecol 1993;100:669-72.
Iijima T, Tada H, Hidaka Y, Mitsuda N, Murata Y, Amino N. Effects of autoantibodies on the course of pregnancy and fetal growth. Obstet Gynecol 1997;90:364-9.
Dendrinos S, Papasteriades C, Tarassi K, Christodoulakos G, Prasinos G, Creatsas G. Thyroid autoimmunity in patients with recurrent spontaneous miscarriages. Gynecol Endocrinol 2000;14:270-4.
Bagis T, Gokcel A, Saygili ES. Autoimmune thyroid disease in pregnancy and the postpartum period: Relationship to spontaneous abortion. Thyroid 2001;11:1049-53.
De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, Cobin RH, et al.
Management of thyroid dysfunction during pregnancy and postpartum: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012;97:2543-65.
Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: Effects on obstetrical complications. J Clin Endocrinol Metab 2006;91:2587-91.
Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al.
Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002;87:489-99.
Bhattacharyya R, Mukherjee K, Das A, Biswas MR, Basunia SR, Mukherjee A. Anti-thyroid peroxidase antibody positivity during early pregnancy is associated with pregnancy complications and maternal morbidity in later life. J Nat Sci Biol Med 2015;6:402-5.
Lazarus JH, Kokandi A. Thyroid disease in relation to pregnancy: A decade of change. Clin Endocrinol (Oxf) 2000;53:265-78.
Stricker R, Echenard M, Eberhart R, Chevailler MC, Perez V, Quinn FA, et al.
Evaluation of maternal thyroid function during pregnancy: The importance of using gestational age-specific reference intervals. Eur J Endocrinol 2007;157:509-14.
Kutteh WH, Yetman DL, Carr AC, Beck LA, Scott RT Jr. Increased prevalence of antithyroid antibodies identified in women with recurrent pregnancy loss but not in women undergoing assisted reproduction. Fertil Steril 1999;71:843-8.
Abbassi-Ghanavati M, Casey BM, Spong CY, McIntire DD, Halvorson LM, Cunningham FG. Pregnancy outcomes in women with thyroid peroxidase antibodies. Obstet Gynecol 2010;116(2 Pt 1):381-6.
Glinoer D. Miscarriage in women with positive anti-TPO antibodies: Is thyroxine the answer? J Clin Endocrinol Metab 2006;91:2500-2.
Prummel MF, Wiersinga WM. Thyroid autoimmunity and miscarriage. Eur J Endocrinol 2004;150:751-5.
Meena A, Nagar P. Pregnancy outcome in euthyroid women with anti-thyroid peroxidase antibodies. J Obstet Gynaecol India 2016;66:160-5.
Männistö T, Vääräsmäki M, Pouta A, Hartikainen AL, Ruokonen A, Surcel HM, et al.
Thyroid dysfunction and autoantibodies during pregnancy as predictive factors of pregnancy complications and maternal morbidity in later life. J Clin Endocrinol Metab 2010;95:1084-94.
[Table 1], [Table 2]
|This article has been cited by|
||Isolated Maternal Hypothyroxinemia and adverse pregnancy outcomes: A systematic review
| ||Fahimeh Ramezani Tehrani,Sima Nazarpour,Samira Behboudi-Gandevani |
| ||Journal of Gynecology Obstetrics and Human Reproduction. 2021; : 102057 |
|[Pubmed] | [DOI]|
||Variations in the Antithyroid Antibody Titre During Pregnancy and After Delivery
| ||Chuyu Li,Na Zhang,Jing Zhou,Wingting Leung,Hans-Jürgen Gober,Zengshu Huang,Xinyao Pan,Lijia Chen,Liang Guan,Ling Wang |
| ||Risk Management and Healthcare Policy. 2021; Volume 14: 847 |
|[Pubmed] | [DOI]|
||Thyroid Function During Pregnancy in A Multiethnic Population in Norway
| ||Line Sletner,Anne Karen Jenum,Elisabeth Qvigstad,Sara Salehi Hammerstad |
| ||Journal of the Endocrine Society. 2021; 5(7) |
|[Pubmed] | [DOI]|
||The Clinical Value and Variation of Antithyroid Antibodies during Pregnancy
| ||Chuyu Li,Jing Zhou,Zengshu Huang,Xinyao Pan,Wingting Leung,Lijia Chen,Yanzhi Zhang,Lan Wang,Yizhen Sima,Hans-Jürgen Gober,Na Zhang,Xuemin Qiu,Lisha Li,Liang Guan,Ling Wang,Olav Lapaire |
| ||Disease Markers. 2020; 2020: 1 |
|[Pubmed] | [DOI]|
||The Need for Dynamic Clinical Guidelines: A Systematic Review of New Research Published After Release of the 2017 ATA Guidelines on Thyroid Disease During Pregnancy and the Postpartum
| ||Allan C. Dong,Mary D. Stephenson,Alex Stewart Stagnaro-Green |
| ||Frontiers in Endocrinology. 2020; 11 |
|[Pubmed] | [DOI]|
||AUTOIMMUNE THYROIDITIS IN PREGNANCY- A CROSS SECTIONAL STUDY IN A TERTIARY CARE HOSPITAL OF SOUTHERN ODISHA
| ||Rini George,Namita Mohanty,Sijoy Kurian |
| ||Journal of Evolution of Medical and Dental Sciences. 2019; 8(2): 117 |
|[Pubmed] | [DOI]|